Immunic, Inc

1200 Avenue of the Americas, Suite 200
New York, NY 10036, USA

Phone: +49 89 2080 477 00
Email: info@imux.com

Immunic AG

Lochhamer Schlag 21
82166 Gräfelfing, Germany

Phone: +49 89 2080 477 00
Email: info@imux.com

Steffi I.

September 8, 2021

Immunic, Inc. to Participate in Investor and Scientific Conferences in September

NEW YORK, September 8, 2021 – Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company...

Read More
August 6, 2021

Immunic, Inc. Reports Second Quarter 2021 Financial Results and Highlights Recent Activity

– Received FDA Clearance to Initiate Twin IMU-838 Phase 3 ENSURE Trials...

Read More